Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2025 Dec 25:2025.12.24.696430.
doi: 10.64898/2025.12.24.696430.

Identification of PAM Requirements for the Vibrio cholerae type I-E CRISPR-Cas System

Affiliations

Identification of PAM Requirements for the Vibrio cholerae type I-E CRISPR-Cas System

Anne M Stringer et al. bioRxiv. .

Abstract

CRISPR-Cas systems are prokaryotic adaptive immune systems that use RNA-guided protein complexes to target invading nucleic acid. A surveillance complex consisting of protein and a CRISPR-RNA (crRNA) binds target nucleic acid via base-pairing interactions, typically leading to processing of the target nucleic acid by a nuclease. CRISPR-Cas systems are classified based on their mechanism of action, with type I systems being the most prevalent in nature. Type I CRISPR-Cas systems target DNA, and require extensive complementarity between the crRNA and the target DNA. Moreover, type I systems require the presence of a "Protospacer Adjacent Motif" (PAM) sequence in the target DNA immediately adjacent to the expected region of base-pairing with the crRNA. Classical biotypes of the bacterial pathogen Vibrio cholerae have active type I-E CRISPR-Cas systems. While the optimal PAM sequence for this CRISPR-Cas system is known to be AAY, the activity of other sequences as possible PAMs has not been determined. Here, we quantify the effectiveness of all possible trinucleotide sequences in the PAM position for the V. cholerae type I-E CRISPR-Cas system. Our data indicate a hierarchy of PAM efficacy, with 15 of the 64 trinucleotide sequences functioning as a PAM.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Conjugation efficiency for protospacer plasmids with each of the 64 possible NNN sequences in the PAM position.
Two plasmid libraries were constructed: one with a protospacer matching the V. cholerae A50 spacer #4, and the other with a protospacer matching #21. Each of the two libraries contained all possible NNN sequences in the PAM position, i.e., 64 plasmids in each library. The scatter-plot shows the normalized efficiency of conjugation of each plasmid into a CRISPR-active strain of V. cholerae. Each datapoint represents a different NNN sequence in the PAM position. Values on the x-axis indicate conjugation efficiencies for plasmids with protospacers matching spacer #4. Values on the y-axis indicate conjugation efficiencies for plasmids with protospacers matching spacer #21. Datapoints for functional PAMs are grouped by color, as follows: AAC, AAT; ATT, ATC; TAC, CAT, CAC, GAT, TAT, GAC, AGC, AAG, AGT; AAA; AGG. Datapoints for all other NNN sequences (i.e., non-functional PAMs) are shown in gray. Values plotted are the mean of two independent biological replicates. Error bars indicate ± one standard deviation from the mean.

References

    1. Bourgeois J., Lazinski D.W., and Camilli A. (2020) Identification of Spacer and Protospacer Sequence Requirements in the Vibrio cholerae Type I-E CRISPR/Cas System. mSphere 5: e00813–20. - PMC - PubMed
    1. Box A.M., McGuffie M.J., O’Hara B.J., and Seed K.D. (2016) Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering. J Bacteriol 198: 578–590. - PMC - PubMed
    1. Brouns S.J.J., Jore M.M., Lundgren M., Westra E.R., Slijkhuis R.J.H., Snijders A.P.L., et al. (2008) Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321: 960–964. - PMC - PubMed
    1. Caliando B.J., and Voigt C.A. (2015) Targeted DNA degradation using a CRISPR device stably carried in the host genome. Nat Commun 6: 6989. - PMC - PubMed
    1. Datsenko K.A., Pougach K., Tikhonov A., Wanner B.L., Severinov K., and Semenova E. (2012) Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun 3: 945. - PubMed

Publication types

LinkOut - more resources